All Pharma articles – Page 37
-
NewsRoyal Pharmaceutical Society warns on drug stock levels
Urgent action is needed to stem shortages of some medicines in the UK as drug wholesalers look to export stocks to profit from the weak pound, a body representing pharmacists has warned.
-
NewsQIPP leads reveal hit list
Slashing follow-up appointments after surgery and spending on drugs will be two of the controversial areas targeted first by the national quality and productivity leads.
-
NewsDH funds £20m pilot scheme for thalidomide survivors
The Department of Health is to fund a £20m pilot scheme to help meet the long term health needs of thalidomide survivors, health minister Mike O’Brien announced today.
-
CommentZimmer frames in the snow and sinister swine flu
Ten days ago it looked as though we would get nothing but blanket coverage of the snow - in both senses - for days on end.
-
NewsNHS prescriptions under review
A 12 week consultation has begun that could pave the way for a revision of the way generic and branded medicines are dispensed within the NHS.
-
HSJ KnowledgeMedicines management
A review in 2007 by the Healthcare Commission into effective medicines management showed that 92% of mental health service users contacted had taken medicines.
-
NewsNHS Direct appoints permanent chair
The acting chair of NHS Direct has had her position made permanent after 20 months in the job.
-
CommentMedia Watch: Good to Great, generic drugs and swine flu
Not of a lot of festive cheer in evidence just yet: the health secretary’s latest strategy for the NHS, intended to take it from “good to great”, was met with a determined lack of enthusiasm from The Daily Telegraph, Independent and Financial Times. They all took the view that it ...
-
NewsNew doctors to be tested on prescriptions
An assessment is being developed to test doctors on their knowledge of medicines to help prevent prescribing errors.
-
NewsNHS operating framework to offer mixed blessings for hospitals
Hospitals will only be paid 30 per cent of the tariff price for emergency procedures they perform over their 2008-09 volume levels, the Department of Health has confirmed.
-
NewsAlistair Darling pledges research and development boost for pharmaceutical industries
Chancellor Alistair Darling has said he wants to encourage research and development in the pharmaceutical and biotechnology industries, announcing a new lower 10 pence corporation tax on income which stems from patents in the UK.
-
NewsPharmacists acting as 'safety net'
Pharmacists are regularly correcting doctors’ mistakes with medicines, according to research.
-
NewsLincolnshire to reward cheaper GP prescribing
GPs in Lincolnshire are being offered incentives worth up to £2 per head of practice population to cut antibiotic prescribing and increase use of generic drugs.
-
NewsNICE highlights guidance to save NHS money
The National Institute for Health and Clinical Excellence has collected together evidence it believes could save the NHS hundreds of millions of pounds.
-
NewsConfused patients appeal for simplified NHS regulation
Health profession regulators should standardise how they work, or even merge, to improve safety, patient groups have said.
-
Community
Dutch fluffiness
If you think British politicians are unhelpful in their tendency to pay more attention to Daily Mail headlines than rational decision making, pity the poor Dutch.
-
NewsDementia drugs warning
Powerful anti-psychotic drugs intended to treat schizophrenia are reportedly being regularly used to “chemically cosh” elderly dementia patients.
-
Information50 Ben Goldacre
An honourable 50th position for the NHS’s own myth buster - The Guardian columnist and author of Bad Science Dr Ben Goldacre.
-
Information36 Richard Barker
Director general of the Association of British Pharmaceutical Industries, Richard Barker has been at the heart of many wrangles over drug costs and availability.
-
Information09 Sir Michael Rawlins
It has been another eventful year for Professor Sir Michael Rawlins, who was reappointed as chair of the National Institute for Health and Clinical Excellence in March after a special exemption allowed him to extend his tenure.